There were 1,972 press releases posted in the last 24 hours and 359,644 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image